Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Decreased by ING Groep NV

ING Groep NV reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 54,194 shares of the medical equipment provider’s stock after selling 18,054 shares during the quarter. ING Groep NV’s holdings in Intuitive Surgical were worth $28,287,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Berbice Capital Management LLC bought a new stake in Intuitive Surgical in the fourth quarter worth about $26,000. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the third quarter worth about $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical in the fourth quarter worth about $36,000. Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical during the 3rd quarter worth about $38,000. Finally, DT Investment Partners LLC lifted its stake in Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of analyst reports. Leerink Partners upped their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. JPMorgan Chase & Co. upped their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Bernstein Bank upped their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Finally, Citigroup upped their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of the stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock worth $3,587,582 over the last 90 days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $606.57 on Friday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The stock’s 50 day moving average price is $564.41 and its 200 day moving average price is $523.46. The company has a market capitalization of $216.05 billion, a P/E ratio of 94.63, a P/E/G ratio of 5.79 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.